Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Samsung Biologics Chooses STARLIMS

Published: Saturday, June 02, 2012
Last Updated: Saturday, June 02, 2012
Bookmark and Share
STARLIMS will provide Samsung its LIMS software to help enhance functional support for quality assurance laboratory testing and for storing and delivering analytical test results.

Samsung is known for electronics not biotechnology, but that could change in future years as Samsung Biologics has opened a new state of the art biologics development and production facility in Incheon, Korea.  To assure ongoing compliance with biologics manufacturing quality standards, Samsung BioLogics chose STARLIMS to be its LIMS provider. 

 “STARLIMS will provide Samsung its LIMS software to help enhance functional support for quality assurance laboratory testing and for storing and delivering analytical test results,” said Thomas Li, account manager, STARLIMS Asia Pacific.  “STARLIMS passed a thorough audit and evaluation by Samsung Biologics, which demonstrates our capability to support the business needs of a world class customer operating a large contract product development and manufacturing facility.”


The new Incheon facility will develop and manufacture a wide range of biologics products through genetic engineering technologies, cell culturing and purification.  By 2013, Samsung Biologics will offer a broad range of mammalian cell based, cGMP manufacturing services for cell line development, process and analytical development, clinical and commercial manufacturing, as well as aseptic fill and finish operations.

 

“Our biologics facility is capable of producing high quality bulk drug products.  We are pleased that our quality control department is relying on STARLIMS leading edge laboratory informatics solutions to help guarantee that all process and final production are high quality, meet global regulatory standards, and maximize customer satisfaction,” said Ming fang Hong, quality control team leader, Samsung Biologics. 



Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
Food and Drug Administration will begin implementing Abbott’s STARLIMS LIMS as part of the agency’s initiative to enhance FDA testing laboratories.
Monday, July 09, 2012
STARLIMS Acquires Distributor in Australia
Abbott has acquired STARLIMS’s Asia Pacific distribution partner.
Saturday, June 02, 2012
STARLIMS Expanding Global Market Presence in Forensics
STARLIMS is expanding its worldwide presence in the forensics market with products and applications designed for crime labs, evidence collection teams and police property rooms.
Saturday, June 02, 2012
STARLIMS to Provide LIMS to Australian Red Cross Blood Services
STARLIMS' LIMS software has been adopted by the Australian Red Cross Blood Services (ARCBS) to manage information and data in its blood products manufacturing and transplantation laboratories.
Saturday, June 02, 2012
Abbott’s STARLIMS Business Acquires Distribution Partners to Build International Presence
Acquisitions part of a series of strategic moves to build Abbott's LIMS business in Europe and emerging markets in Latin America and Africa
Saturday, May 12, 2012
STARLIMS Expands Global Customer Service and Support
Resources from Abbott help build new, global customer care organization
Wednesday, April 25, 2012
STARLIMS Acquires International Distribution Partners
STARLIMS Technologies, an Abbott company, has announced the acquisition of several longtime distribution partners
Sunday, March 11, 2012
StarLIMS wins FDA software deal
The company will supply its lab management solutions for FDA testing laboratories.
Wednesday, February 01, 2012
Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
STARLIMS and Abbott have announced that the FDA will begin implementing STARLIMS LIMS solution as part of the agency’s initiative to enhance FDA’s testing laboratories.
Tuesday, January 24, 2012
Dr Lal PathLabs Selects STARLIMS Software for LIMS
STARLIMS will be implemented for use in its entire network consisting of the National Reference Lab (NRL) in New Delhi
Tuesday, November 29, 2011
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!